title: [Combined treatment of palmoplantar syndrome in patients under antitumor therapy].
abstract: Observation covered 12 patients under various antitumor medications. Group 1 was formed of patients with developed palmoplantar syndrome varying in severity, who received complex treatment including IR-therapy and local antioxidant medication. Group 2 included patients without palmoplantar syndrome, who received preventive treatment with IR-therapy. All patients of group 1 demonstrated lower severity of palmoplantar syndrome manifestations. In group 2, 80% of the patients avoided palmoplantar syndrome development, and 20% of the patients had light course of the syndrome manifestations. Patients at high risk of palmoplantar syndrome under antitumor therapy are recommended to undergo IR-therapy and local antioxidant medication.
authors.forename: L S
authors.initials: LS
authors.lastname: Kruglova
authors.forename: E A
authors.initials: EA
authors.lastname: Shatokhina
authors.forename: M A
authors.initials: MA
authors.lastname: Elfimov
authors.forename: V E
authors.initials: VE
authors.lastname: Illarionov
authors.forename: A V
authors.initials: AV
authors.lastname: Chervinskaya
authors.forename: V V
authors.initials: VV
authors.lastname: Portnov
authors.forename: E V
authors.initials: EV
authors.lastname: Filatova
authors.forename: M S
authors.initials: MS
authors.lastname: Petrova
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000975:Antioxidants / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D060831:Hand-Foot Syndrome / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007259:Infrared Rays / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010789:Phototherapy / Q000379:methods*; D008517:Phytotherapy / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D000975:Antioxidants